1. Home
  2. FNA vs BVS Comparison

FNA vs BVS Comparison

Compare FNA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNA
  • BVS
  • Stock Information
  • Founded
  • FNA 2010
  • BVS 2011
  • Country
  • FNA United States
  • BVS United States
  • Employees
  • FNA N/A
  • BVS N/A
  • Industry
  • FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • FNA Health Care
  • BVS Health Care
  • Exchange
  • FNA Nasdaq
  • BVS Nasdaq
  • Market Cap
  • FNA 852.1M
  • BVS 883.7M
  • IPO Year
  • FNA 2021
  • BVS 2021
  • Fundamental
  • Price
  • FNA $10.70
  • BVS $11.39
  • Analyst Decision
  • FNA Strong Buy
  • BVS Strong Buy
  • Analyst Count
  • FNA 5
  • BVS 3
  • Target Price
  • FNA $15.60
  • BVS $15.00
  • AVG Volume (30 Days)
  • FNA 550.3K
  • BVS 297.3K
  • Earning Date
  • FNA 11-12-2024
  • BVS 11-05-2024
  • Dividend Yield
  • FNA N/A
  • BVS N/A
  • EPS Growth
  • FNA N/A
  • BVS N/A
  • EPS
  • FNA N/A
  • BVS N/A
  • Revenue
  • FNA $244,995,000.00
  • BVS $555,061,000.00
  • Revenue This Year
  • FNA $18.58
  • BVS $11.24
  • Revenue Next Year
  • FNA $14.85
  • BVS $6.77
  • P/E Ratio
  • FNA N/A
  • BVS N/A
  • Revenue Growth
  • FNA 18.16
  • BVS 10.40
  • 52 Week Low
  • FNA $4.65
  • BVS $3.90
  • 52 Week High
  • FNA $14.79
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • FNA 60.03
  • BVS 43.94
  • Support Level
  • FNA $10.19
  • BVS $10.95
  • Resistance Level
  • FNA $11.00
  • BVS $11.54
  • Average True Range (ATR)
  • FNA 0.51
  • BVS 0.48
  • MACD
  • FNA -0.13
  • BVS -0.04
  • Stochastic Oscillator
  • FNA 43.20
  • BVS 13.84

About FNA Paragon 28 Inc.

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: